| 常用名 | Ladarixin sodium | CAS号 | 865625-56-5 |
|---|---|---|---|
| 价格 | 纯度 | 98.0% | |
| 备货期 | 10天 | 库存 | 现货 |
| 产品详情(用途,包装等)
用途: A novel allosteric, noncompetitive dual CXCR1/2 inhibitor that inhibits human polymorphonuclear leukocyte (PMN) migration to CXCL8 in vitro with IC50 of 0.7 nM; prevents PMN infiltration and tissue damage in several models of IR injury in vivo; abrogates motility and induces apoptosis in cultured cutaneous and uveal melanoma cells and xenografts; also prevents inflammation-mediated damage in MLD-STZ, prevents and reverses diabetes in NOD mice. Diabetes Phase 2 Clinical 物理化学性质: CAS号:865625-56-5 常用中文名:Ladarixin sodium 常用英文名:Ladarixin sodium 分子式:C11H11F3NNaO6S2 分子量:397.323 密度:N/A 沸点:N/A 熔点:N/A 闪点:N/A |